阿克提斯肿瘤 AKTS
$15.82 +$0.97 (+6.53%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.82 0.00%
开盘$14.85
昨收$14.85
当日区间$14.82 – $16.10
成交量362.9K
市值$879.90M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$3.38M+111.4% YoY
营业利润-$28.90M-37.9% YoY
净利润-$24.14M-33.6% YoY
摊薄每股收益-$0.44-27.9% YoY
自由现金流-$21.85M-23.3% YoY
经营现金流-$20.59M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-866.6%
净利率-727.0%
净资产收益率-15.1%
资产收益率-13.1%
投入资本回报率-17.6%
流动比率16.33
负债/资产比率13.0%
现金及投资$517.32M
总负债$9.76M
净现金（净负债）$507.56M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $3.38M | $3.23M | $6.50M | $1.87M | $1.58M |
| 营业总收入 | $3.38M | $3.23M | $6.50M | $1.87M | $1.58M |
| 营业费用 | $32.28M | $25.93M | $81.18M | $19.25M | $19.78M |
| 销售及管理费用 | $6.40M | $5.34M | $12.60M | $2.51M | $3.06M |
| -管理费用 | $6.40M | $5.34M | $12.60M | $2.51M | $3.06M |
| 研发费用 | $25.28M | $20.04M | $67.45M | $16.49M | $16.47M |
| 折旧、摊销与折耗 | $599,000.00 | $556,000.00 | $1.13M | $242,000.00 | $254,000.00 |
| -折旧与摊销 | $599,000.00 | $556,000.00 | $1.13M | $242,000.00 | $254,000.00 |
| 营业利润 | -$28.90M | -$22.71M | -$74.68M | -$17.38M | -$18.20M |
| 非经营性利息净收入（支出） | $4.77M | $4.38M | $11.01M | $2.25M | $2.68M |
| 非经营性利息收入 | $4.77M | $4.38M | $11.01M | $2.25M | $2.68M |
| 其他收入（支出） | -$10,000.00 | -$3,000.00 | -$56,000.00 | -$11,000.00 | -$12,000.00 |
| 其他非经营性收入（支出） | -$10,000.00 | -$3,000.00 | -$56,000.00 | -$11,000.00 | -$12,000.00 |
| 税前利润 | -$24.14M | -$18.33M | -$63.73M | -$15.14M | -$15.53M |
| 净利润 | -$24.14M | -$18.33M | -$63.73M | -$15.14M | -$15.53M |
| 持续经营利润 | -$24.14M | -$18.33M | -$63.73M | -$15.14M | -$15.53M |
| 归属母公司净利润 | -$24.14M | -$18.33M | -$63.73M | -$15.14M | -$15.53M |
| 归属普通股股东净利润 | -$24.14M | -$18.33M | -$63.73M | -$15.14M | -$15.53M |
| 基本每股收益 | -$0.44 | -$0.38 | -$1.21 | -$0.29 | -$0.30 |
| 摊薄每股收益 | -$0.44 | -$0.38 | -$1.21 | -$0.29 | -$0.30 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $557.60M | $576.80M | $264.89M | $264.89M | $279.04M |
| 流动资产合计 | $524.54M | $543.94M | $230.31M | $230.31M | $249.42M |
| 现金及现金等价物与短期投资 | $517.32M | $538.48M | $226.79M | $226.79M | $246.22M |
| -现金及现金等价物 | $82.49M | $371.63M | $37.78M | $37.78M | $180.25M |
| -短期投资 | $434.83M | $166.85M | $189.00M | $189.00M | $65.97M |
| 其他流动资产 | $7.22M | $5.46M | $3.52M | $3.52M | $3.20M |
| 非流动资产合计 | $33.06M | $32.86M | $34.58M | $34.58M | $29.62M |
| 固定资产净值 | $28.20M | $28.11M | $27.25M | $27.25M | $24.30M |
| -固定资产原值 | $35.27M | $34.31M | $32.79M | $32.79M | $29.15M |
| -累计折旧 | -$7.08M | -$6.20M | -$5.55M | -$5.55M | -$4.85M |
| 其他非流动资产 | $4.86M | $4.75M | $7.33M | $7.33M | $5.32M |
| 负债合计 | $72.76M | $70.69M | $411.03M | $411.03M | $411.43M |
| 流动负债合计 | $32.13M | $27.91M | $31.24M | $31.24M | $26.91M |
| 应付款 | $2.53M | $1.23M | $1.74M | $1.74M | $2.36M |
| -应付账款 | $2.53M | $1.23M | $1.74M | $1.74M | $2.36M |
| 一年内应计费用 | $8.19M | $5.05M | $4.96M | $4.96M | $4.28M |
| 短期债务及融资租赁负债 | $1.48M | $1.43M | $1.32M | $1.32M | $1.37M |
| -一年内到期融资租赁负债 | $1.48M | $1.43M | $1.32M | $1.32M | $1.37M |
| 一年内递延负债 | $17.34M | $18.96M | $18.66M | $18.66M | $16.08M |
| 非流动负债合计 | $40.63M | $42.78M | $379.80M | $379.80M | $384.52M |
| 长期债务及融资租赁负债 | $9.76M | $10.15M | $10.23M | $10.23M | $10.50M |
| -长期融资租赁负债 | $9.76M | $10.15M | $10.23M | $10.23M | $10.50M |
| 一年以上递延负债 | $30.87M | $32.63M | $36.16M | $36.16M | $40.61M |
| 可转换优先证券 | $0.00 | $0.00 | $333.41M | $333.41M | $333.41M |
| 股东权益合计 | $484.84M | $506.11M | -$146.15M | -$146.15M | -$132.39M |
| 股东权益 | $484.84M | $506.11M | -$146.15M | -$146.15M | -$132.39M |
| 股本 | $5,000.00 | $5,000.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $5,000.00 | $5,000.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $684.61M | $681.23M | $10.37M | $10.37M | $9.02M |
| 留存收益 | -$199.03M | -$174.89M | -$156.56M | -$156.56M | -$141.43M |
| 不影响留存收益的损益 | -$745,000.00 | -$241,000.00 | $42,000.00 | $42,000.00 | $16,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$20.59M | -$24.24M | -$64.13M | -$15.24M | -$15.22M |
| 持续经营经营活动现金流净额 | -$20.59M | -$24.24M | -$64.13M | -$15.24M | -$15.22M |
| 持续经营净利润 | -$24.14M | -$18.33M | -$63.73M | -$15.14M | -$15.53M |
| 折旧、折耗与摊销 | $879,000.00 | $652,000.00 | $2.33M | $695,000.00 | $598,000.00 |
| 营运资金变动 | $489,000.00 | -$9.06M | -$3.23M | -$1.19M | -$820,000.00 |
| -应收款变动 | -$144,000.00 | -$1.11M | $1.03M | $804,000.00 | $257,000.00 |
| -预付资产变动 | -$1.62M | -$828,000.00 | -$872,000.00 | -$1.13M | $298,000.00 |
| -应付账款及应计费用变动 | $5.50M | -$1.89M | $2.16M | $903,000.00 | -$448,000.00 |
| -其他流动资产变动 | $488,000.00 | -$1.69M | $1.35M | $417,000.00 | -$38,000.00 |
| -其他流动负债变动 | -$350,000.00 | -$327,000.00 | -$1.40M | -$317,000.00 | -$309,000.00 |
| -其他营运资金变动 | -$3.38M | -$3.23M | -$5.50M | -$1.87M | -$580,000.00 |
| 投资活动现金流净额 | -$268.71M | $20.54M | $65.96M | -$126.46M | $85.23M |
| 持续经营投资活动现金流净额 | -$268.71M | $20.54M | $65.96M | -$126.46M | $85.23M |
| 固定资产购置及出售净额 | -$1.26M | -$1.85M | -$9.58M | -$4.15M | -$2.00M |
| 投资购置及出售净额 | -$267.45M | $22.40M | $75.55M | -$122.30M | $87.24M |
| 筹资活动现金流 | $156,000.00 | $337.55M | -$1.21M | -$772,000.00 | $28,000.00 |
| 持续经营筹资活动现金流净额 | $156,000.00 | $337.55M | -$1.21M | -$772,000.00 | $28,000.00 |
| 普通股发行净额 | $0.00 | $339.78M | – | – | – |
| 股票期权行使所得 | $156,000.00 | $30,000.00 | $336,000.00 | $258,000.00 | $28,000.00 |
| 其他筹资费用净额 | $0.00 | -$2.26M | -$1.55M | -$1.03M | $0.00 |
| 期末现金余额 | $83.64M | $372.78M | $38.93M | $38.93M | $181.40M |
| 现金净变动 | -$289.14M | $333.85M | $625,000.00 | -$142.47M | $70.04M |
| 期初现金余额 | $372.78M | $38.93M | $38.31M | $181.40M | $111.36M |
| 自由现金流 | -$21.85M | -$26.10M | -$73.71M | -$19.40M | -$17.23M |
| 优先股发行净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 AKTS。
登录后参与讨论。